Molecular characterization of influenza B viruses circulating in northern Italy during the 2001-2002 epidemic season-Reference-Cited by-同舟云学术

Molecular characterization of influenza B viruses circulating in northern Italy during the 2001-2002 epidemic season

Published:2003-05-06 Issue:3 Volume:70 Page:463-469
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J. Med. Virol.

Author:

Ansaldi Filippo,D'Agaro Pierlanfranco,de Florentiis Daniela,Puzelli Simona,Lin Yi Pu,Gregory Victoria,Bennett Michael,Donatelli Isabella,Gasparini Roberto,Crovari Pietro,Hay Alan,Campello Cesare

Publisher

Wiley

Subject

Infectious Diseases,Virology

Reference19 articles.

1. Evolutionary changes in influenza B are not primarily governed by antibody selection.

2. Antigenic structure of the influenza B virus hemagglutinin: nucleotide sequence analysis of antigenic variants selected with monoclonal antibodies

3. The molecular epidemiology of influenza viruses

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of Cross-Reactive Live Attenuated Influenza Vaccine Candidates against Both Lineages of Influenza B Virus;Vaccines;2024-01-18

2. Epidemiology and molecular characterization of influenza viruses, human parechoviruses and enteroviruses in children up to 5 years with influenza-like illness in Northern Italy during seven consecutive winter seasons (2010–2017);Journal of General Virology;2017-11-01

3. Trends of influenza B during the 2010–2016 seasons in 2 regions of north and south Italy: The impact of the vaccine mismatch on influenza immunisation strategy;Human Vaccines & Immunotherapeutics;2017-08-03

4. Fifteen years of epidemiologic, virologic and syndromic influenza surveillance: A focus on type B virus and the effects of vaccine mismatch in Liguria region, Italy;Human Vaccines & Immunotherapeutics;2016-12-07

5. Immunogenicity and safety of inactivated quadrivalent influenza vaccine in adults: A systematic review and meta-analysis of randomised controlled trials;Vaccine;2016-07